CELZ 株価推移チャート
CELZ 収入
Creative Medical Technology Holdings Inc
$0.79
-2.08%
$-0.01
終値： Jul 27, 16:00:00 GMT-4
$0.77
-2.81%
$-0.02
アフターマーケット：Jul 27, 18:02:17 GMT-4
戻る
Creative Medical Technology Holdings Inc (CELZ) 収入
最新の利益結果: Q1 '26
報告済み: 2026-05-08
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
CELZの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Creative Medical Technology Holdings Inc CELZの前四半期の収益はどうでしたか？
Creative Medical Technology Holdings Incの収益見積もりはいくらですか？
Creative Medical Technology Holdings Incの収益品質スコアはどれくらいですか？
Creative Medical Technology Holdings Incはいつ収益を報告しますか？
Creative Medical Technology Holdings Incの予想収益はいくらですか？
Creative Medical Technology Holdings Incは収益予想を上回りましたか？
主要データ
前終値
$0.8102
始値
$0.7912
当日レンジ
$0.77 - $0.7968
52週レンジ
$0.771 - $6.25
取引高
98.8K
平均取引高
2.2M
配当利回り
--
1株当たり利益(TTM)
-2.40
時価総額
$2.8M
CELZとは何ですか？
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The company is headquartered in Phoenix, Arizona and currently employs 4 full-time employees. The company went IPO on 2009-05-01. The firm conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
